Close

Treatments

Proton Beam Therapy

Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.

Radiotherapy

Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.

MR-linac radiotherapy

The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity available at the Rutherford Cancer Centre North West in Liverpool in 2021.

Videos

What is an infusion therapy?

What is an infusion therapy?

Play Video
What is proton beam therapy?

What is proton beam therapy?

Play Video
Rutherford Cancer Centre North West – Look around our fourth centre in Liverpool

Rutherford Cancer Centre North West – Look around our fourth centre in Liverpool

Play Video
What is radiotherapy?

What is radiotherapy?

Play Video

News & Press

BLOG: What is proton beam therapy? Who might benefit?

BLOG: What is proton beam therapy? Who might benefit?

19/11/2020

Read More
Late stage cancers increase as Covid fall-out bites

Late stage cancers increase as Covid fall-out bites

03/11/2020

Read More
BLOG: Men’s cancers and mental wellness

BLOG: Men’s cancers and mental wellness

02/11/2020

Read More
BLOG: Men. Are you breast cancer aware?

BLOG: Men. Are you breast cancer aware?

22/10/2020

Read More
BLOG: What is the difference between chemotherapy and immunotherapy?

BLOG: What is the difference between chemotherapy and immunotherapy?

09/10/2020

Read More

© Rutherford Health plc

Site by i3MEDIA

Get in Touch or call 0800 210 0402

Dr Brinda Sethugavalar

Home Consultants Dr Brinda Sethugavalar

Rutherford Location

Rutherford Cancer Centre
North East

Telephone
01670 339650
Email
enquiries@therutherford.com
Leave a message

Specialities

  • Breast
  • Lymphoma
  • Non-Melanoma Basal cell carcinoma (BCC)
  • Non-Melanoma Squamous Cell Carcinoma (SCC)
  • Proton Beam Therapy
  • Skin

Biography

Dr Brinda Sethugavalar studied primary medical education at the University of Dundee Medical School and obtained MBChB in 2004. She completed her specialist registrar training in Leeds Teaching Hospitals in 2015. Dr Brinda Sethugavalar obtained her fellowship at the Royal College of Radiology (RCR) in 2013. She specialises in breast cancer, lymphoma radiotherapy and non-melanoma skin cancers.

Qualifications

  • MBChB
  • MRCP
  • FRCR

Proton Beam Therapy

This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.

Find out more about Proton Beam Therapy

Memberships

Fellowship of Royal College of Radiology (FRCR) - 2013

Membership of the Royal College of Physicians (MRCP)

Research interests

 Dr Brinda Sethugavalar's research interests include: 

  • Royal College of Radiology (RCR) - a national audit on early and locally advanced breast cancer. Data collection of radiotherapy patients within the department has shown that results are in line with RCR recommendations.
  • FASTFORWARD study - Dr Brinda Sethugavalar is the PI for this study, it looks into Hypofractionated radiotherapy in breast cancer. She was involved in patient recruitment and contouring of individual cases. 
  • IDRIS study - radiotherapy and lenolidomide in patients with solitary plasmacytoma. Dr Brinda Sethugavalar outlined the benchmark cases for national peer review. This is currently waiting for the trial to open for recruitment following QA (quality assuarance).
  • POSNOC - a trial on radiotherapy or surgery vs observation in low risk breast cancer. Dr Brinda Sethugavalar is involved in patient selection at MDT level.
  • IMPORT High - long term follow up and assessment of toxicity.

Declaration

  1. Dr Brinda Sethugavalar does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
  2. Dr Brinda Sethugavalar does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
  3. Dr Brinda Sethugavalar does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.

Get in Touch

If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or

Get in Touch

Our Trusted Healthcare Partners

Rutherford Cancer Centre Locations

Our Treatments
Patient Info
About Us
More
Rutherford Health plc
Rutherford Estates
Rutherford Innovations
Rutherford Diagnostics

© Rutherford Health plc

Site by i3MEDIA